FULL PAPERS
Transformation of Contact-Explosives Primary Amines Iodine(III)
1H), 7.71 (d, J=8 Hz, 1H), 7.62 (d, J=8 Hz, 1H), 7.38–7.27
(m, 6H), 6.43 br (s, 1H), 4.635 (d, J=4 Hz, 2H); 13C NMR
(100 MHz, CDCl3): d=166.1, 137.9, 136.4, 134.6, 130.3,
127.86, 127.43, 118.09, 115.36, 77.48, 77.16, 76.84, 42.54; IR
˜
(KBr): n=3415 (w), 2923 (s), 2848 (s), 2230 (s), 1648 (m),
1543 (s), 1288 (s), 858(s), 750 (m) cmÀ1; HR-MS (ESI-TOF):
m/z=271.0640, calcd. for C15H12ClN2O (M+H+): 271.0632.
4-Bromo-N-(2-chlorobenzyl)benzamide (3n): Rf =0.37
(ethyl acetate/hexane=1:4); white solid; yield 84% (83 mg,
˜
130.3, 129.0, 128.1, 127.9, 125.7, 122.9, 44.4; IR (KBr): n=
3320 (m), 3063 (s), 3028 (s), 2925 (s), 1638 (m), 1562 (m),
1542 (m), 1471 (s), 1454 (s), 1315 (s), 1071 (s), 996 (s), 894
(s), 744 (m), 698 (m) cmÀ1; HR-MS (ESI-TOF): m/z=
290.0189, calcd. for C14H13BrNO (M+H+): 290.0175.
1
68%); mp 138–1398C; H NMR (400 MHz, CDCl3): d=7.65
(d, J=8 Hz, 2H), 7.56 (d, J=8 Hz, 2H), 7.46 (dd, J=6,
4 Hz, 1H), 7.39 (dd, J=8, 4 Hz, 1H), 7.27–7.24 (m, 2H),
6.56 (br s, 1H), 4.72 (d, J=8 Hz, 2H); 13C NMR (100 MHz,
CDCl3): d=166.5, 135.4, 133.9, 133.2, 132.0, 130.7, 129.8,
4-Cyano-N-(4-fluorobenzyl)benzamide
(3i):
Rf =0.20
(ethyl acetate/hexane=1:4); white solid; yield: 92%
(100 mg, 74%); mp 109–1118C; 1H NMR (400 MHz,
CDCl3): d=7.88 (d, J=8 Hz, 2H), 7.72 (d, J=8 Hz, 2H),
7.31 (dd, J=10, 6 Hz, 2H), 7.03 (dd, J=12, 5 Hz, 2H), 6.59
(br s, 1H), 4.60 (d, J=8 Hz, 2H); 13C NMR (100 MHz,
˜
129.3, 128.7, 127.4, 126.4, 42.3; IR (KBr) n=3320 (m), 3068
(s), 1633 (m), 1590 (s), 1539 (m), 1482 (m), 1318 (m), 1070
(s), 1009 (s), 847 (s), 749 (m) cmÀ1; HR-MS (ESI-TOF):
m/z=323.9794, calcd. for C14H12BrClNO (M+H+):
323.9785.
1
CDCl3): d=165.7, 162.5 (d, JC,F =245 Hz), 138.2, 133.5 (d,
3
4JC,F =3 Hz), 132.6, 129.8 (d, JC,F =8 Hz), 127.8, 118.0, 115.9
2
˜
(d, JC,F =21 Hz), 115.3, 43.7; IR (KBr): n=3265 9 m), 3094
N-Benzyl-2,3,4,5,6-pentafluorobenzamide (3o): Rf =0.45
(ethyl acetate/hexane=1:4); white solid; yield: 78% (63 mg,
(m), 2922 (m), 2852 (s), 2230 (m), 1633 (m), 1556 (m), 1512
(m), 1428 (s), 1251 (s), 1220 (m), 1154 (s), 1059 (s), 861 (m),
840 (m), 807 (m), 731 (s), cmÀ1; HR-MS (ESI-TOF): m/z=
255.0925, calcd. for C15H12FN2O (M+H+): 255.0928.
1
59%); mp 2158C; H NMR (400 MHz, CDCl3): d=7.38–7.29
(m, 5H), 6.42 (br s, 1H), 4.61 (d, J=8 Hz, 2H); 13C NMR
(100 MHz, CDCl3): d=157.5, 145.7–145.4 (m), 143.9–143.5
(m), 143.2–142.9 (m), 141.3–141.0, 139.2–138.8 (m), 136.7–
136.3 (m), 129.0, 128.1, 127.8, 111.7–111.3 (m), 44.5; IR
4-Bromo-N-(4-fluorobenzyl)benzamide (3j): Rf =0.35
(ethyl acetate/hexane=1:4); white solid; yield: 83% (80 mg,
1
69%); mp 128–1318C; H NMR (400 MHz, CDCl3): d=7.63
˜
(KBr): n=3235 (m), 3068 (m), 2953 (m), 1652 (m), 1566 (s),
(d, J=8.5 Hz, 2H), 7.53 (d, J=8.5 Hz, 2H), 7.28 (dd, J=8.3,
5.5 Hz, 2H), 7.01 (t, J=8.6 Hz, 2H), 6.65 (br s, 1H), 4.55 (d,
J=5.7 Hz, 2H); 13C NMR (100 MHz, CDCl3): d=166.6,
1494 (m), 1059 (s), 988 (m), 875 (s), 746 (s) cmÀ1; HR-MS
(ESI-TOF): m/z=302.0588, calcd. for C14H9F5NO (M+H+):
302.0599.
1
4
162.4 (d, JC,F =244 Hz), 133.9 (d, JC,F =3 Hz), 133.1, 131.9,
N-Benzylpyrene-1-carboxamide (3p): Rf =0.32 (ethyl ace-
tate/hexane=1:4); white solid; yield: 81% (49 mg, 48%);
mp 1058C; 4:3 mixture of rotamers; 1H NMR (400 MHz,
CDCl3): d=8.57 (dd, J=9.2, 3.5 Hz, 1H), 8.28–8.16 (m,
2H), 8.16–7.93 (m, 6H), 7.84–7.71 (m, 3H), 7.52–7.37 (m,
8H), 7.37–7.27 (m, 8H), 6.60 (s, 1H), 6.49 (s, 1H), 4.87–4.73
(m, 2H), 4.71–4.54 (m, 3H); 13C NMR (100 MHz, CDCl3):
d=169.9, 167.4, 138.3, 138.3, 134.4, 132.6, 131.6, 131.2, 130.8,
130.8, 128.9, 128.9, 128.8, 128.7, 128.6, 128.1, 128.0, 127. 8,
127.7, 127.2, 127.1, 126.4, 125.9, 125.8, 124.8, 124.6, 124.5,
129.7 (d, 3JC,F =8 Hz), 128.7, 126.4, 115.7 (d, JC,F =21 Hz),
2
˜
43.5; IR (KBr): n=3315 (m), 3081 (s), 1638 (m), 1548 (m),
1227 (s), 841 (s), 801 (s), 711 (s) cmÀ1; HR-MS (ESI-TOF):
m/z=308.0099, calcd. for C14H12BrFNO (M+H+): 308.0081.
N-(4-Fluorobenzyl)-4-nitrobenzamide
(3k):
Rf =0.30
(ethyl acetate/hexane=1:4); white solid; yield: 86% (85 mg,
1
67%); mp 129–1328C; H NMR (400 MHz, CDCl3): d=8.27
(d, J=8 Hz, 2H), 7.94 (d, J=8 Hz, 2H), 7.33 (s, 2H), 7.04
(t, J=8.1 Hz, 2H), 6.57 (br s, 1H), 4.625 (d, J=4 Hz, 2H);
1
13C NMR (100 MHz, CDCl3): d=165.4, 162.5 (d, JC,F
=
=
˜
124.4, 77.9, 77.2, 76.8, 44.8, 44.2; IR (KBr): n=3288 (m),
4
3
245 Hz), 149.8, 139.9, 133.4 (d, JC,F =3 Hz), 129.9 (d, JC,F
3063 (s), 3030 (s), 2923 (s), 1635 (m), 1537 (m), 1490 (s),
1291 (m), 848 (s), 695 (m) cmÀ1; HR-MS (ESI-TOF): m/z=
336.1393, calcd. for C24H18NO (M+H+): 336.1383.
2
9 Hz), 128.3, 124.0, 115.9 (d, JC,F =22 Hz), 43.8; IR (KBr):
˜
n=3271 (m), 3077 (s), 2923 (m), 2853 (m), 1644 (m), 1600
(m), 1548 (m), 1510 (m), 1349 (m), 1219 (m), 1156 (s), 1064
(s), 981 (s), 824 (m), 723 (m) cmÀ1; HR-MS (ESI-TOF):
m/z=275.0829, calcd. for C14H12FN2O3 (M+H+): 275.0826.
N-(2-Chlorobenzyl)-4-nitrobenzamide (3l): Rf =0.45 (ethyl
acetate/hexane=1:4); white solid; yield: 87% (93 mg, 69%);
4-Cyano-N-phenethylbenzamide (3q): Rf =0.18 (ethyl ace-
tate/hexane=1:4); white solid; yield: 94% (91 mg, 68%);
1
mp 115–1178C; H NMR (400 MHz, CDCl3): d=7.77 (d, J=
8 Hz, 2H), 7.70 (d, J=8 Hz, 2H), 7.35–7.32 (m, 2H), 7.28–
7.22 (m, 3H), 6.21 (br s, 1H), 3.76–3.71 (m, 2H), 2.95 (t, J=
6.9 Hz, 2H); 13C NMR (100 MHz, CDCl3): d=165.8, 138.6,
132.5, 128.9, 128.9, 127.6, 126.9, 118.1, 115.1, 41.4, 35.6; IR
1
mp 163–1668C; H NMR (400 MHz, CDCl3): d=8.27 (d, J=
8 Hz, 2H), 7.93 (d, J=8 Hz, 2H), 7.48–7.38 (m, 2H), 7.29–
7.25 (m, 2H), 6.69 (br s, 1H), 4.745 (d, J=4 Hz, 2H);
13C NMR (100 MHz, CDCl3): d=165.3, 149.6, 139.8, 134.9,
133.8, 130.8, 129.7, 129.5, 128.2, 127.3, 123.8, 42.5; IR (KBr):
˜
(KBr): n=3306 (w), 3085 (s), 2923 (s), 2852 (s), 2228 (s),
1633 (m), 1543 (m), 1497 (s), 1313 (s), 857 (s), 753 (s) cmÀ1
;
HR-MS (ESI-TOF): m/z=251.1192, calcd. for C16H15N2O
˜
n=3331 (m), 3063 (s), 2920 (m), 2857 (s), 1644 (m), 1598
(M+H+): 251.1178.
(m), 1523 (m), 1345 (m), 1300 (m), 1015 (s), 752 (s) cmÀ1
;
4-Bromo-N-phenethylbenzamide (3r): Rf =0.35 (ethyl ace-
tate/hexane=1:4); white solid; yield: 87% (71 mg, 62%);
mp 113–1168C (lit.[33] 143–1448C); 1H NMR (400 MHz,
CDCl3): d=7.55 (s, 4H), 7.35–7.32 (m, 2H), 7.27–7.22 (m,
3H), 6.08 (br s, 1H), 3.71 (dd, J=12, 8 Hz, 2H), 2.93 (t, J=
6.9 Hz, 2H); 13C NMR (100 MHz, CDCl3): d=166.6, 138.8,
133.5, 131.9, 131.8, 128.9, 128.5, 126.8, 126.2, 41.3, 35.7; IR
HR-MS (ESI-TOF): m/z=291.0537, calcd. for C14H12ClN2O3
(M+H+): 291.0531.
N-(2-Chlorobenzyl)-4-cyanobenzamide (3m): Rf =0.30
(ethyl acetate/hexane=1:4); white solid; yield; 88% (92 mg,
1
64%); mp 132–1358C; H NMR (400 MHz, CDCl3): d=7.87
(d, J=8.3 Hz, 2H), 7.72 (d, J=8.2 Hz, 2H), 7.51–7.43 (m,
1H), 7.43–7.36 (m, 1H), 7.30–7.25 (m, 2H), 6.70 (s, 1H),
4.73 (d, J=5.9 Hz, 2H); 13C NMR (100 MHz, CDCl3): d=
165.67, 138.29, 135.10, 133.94, 132.61, 130.83, 129.86, 129.55,
˜
(KBr): n=3419 (w), 2923 (s), 2848 (s), 1639 (m), 1542 (s),
1482 (s), 1317 (s), 1068 (s), 1009 (s), 755 (s) cmÀ1; HR-MS
Adv. Synth. Catal. 2015, 357, 3977 – 3985
ꢂ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3983